Akso Health Group current report, Q4 FY2019

SEC Filing Summary: Hexindai Inc. (Form 6-K)

Business Context and Reporting Period

This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of December 2019. The filing date is December 30, 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing serves to distribute a press release (Exhibit 99.1) but does not contain the full text of that release within the provided content.

Financial Metrics

The provided filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The document consists solely of the cover page, signature block, and exhibit index.

Material Changes

No material changes versus the prior comparable period are described in the provided text, as no financial data or operational updates are included in the excerpt.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumably contained in the referenced Exhibit 99.1 (Press Release), which is not included in the input.

Key Facts for Investor Verification

  • Verify the content of Exhibit 99.1 (Press Release) to obtain actual financial results or operational updates for December 2019.
  • Confirm the identity of the registrant; the input metadata mentions "Akso Health Group," but the filing text explicitly identifies the registrant as "Hexindai Inc."
  • Note that this filing is a procedural submission to distribute a press release rather than a detailed financial report.